Type: Keyphrase
Name: aldesleukin
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Targeting of bone marrow neovasculature

Antibodies which bind an antigen of the bone marrow neovasculature in leukaemia patients, for use in treatment and diagnosis of leukaemia, in particular the treatment and diagnosis of acute myeloid leukaemia (AML).Description of the InventionThe present ... [Published PharmCast - Apr 11 2014]
First reported Jan 05 2014 - Updated Jan 05 2014 - 1 reports

Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers

The present invention relates to nucleic acids and polypeptides encoded thereby, whose expression is modulated in brain microvascular endothelial cells undergoing early dynamic inflammation-induced changes in blood-brain bather functionality. Such polypeptides ... [Published PharmCast - Jan 05 2014]

More Content

All (3) | News (3) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Targeting of bone marrow neovasculature [Published PharmCast - Apr 11 2014]
Methods and compositions for targeting agents i... [Published PharmCast - Jan 05 2014]
Cupredoxin derived transport agents and methods... [Published PharmCast - Sep 25 2013]
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.